InsiderTrades

Form 4 for WLTH WEALTHFRONT CORP

Accepted 2025-12-15 00:00:00 ET · period of report 2025-09-05 · accession 0002082642-25-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-12-15 2025-09-05+ WLTH Imberman Alan CFO, Treas M - OptEx $0.2675 +366.3K 334.9K New +$98.0K
D 2025-12-15 2025-12-11 WLTH Imberman Alan CFO, Treas S - Sale+OE $14.00 -100.0K 186.9K -35% -$1.40M
D 2025-12-15 2025-12-11 WLTH Imberman Alan CFO, Treas F - Tax $14.00 -118.9K 286.9K -29% -$1.66M
DM 2025-12-15 2025-09-05+ WLTH Imberman Alan CFO, Treas M - OptEx $0.00 -366.3K 0 -100% $0
D 2025-12-15 2025-10-13 WLTH Imberman Alan CFO, Treas A - Grant $0.00 +284.2K 284.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-05 M A 40,000 $2.45 79,411 D — — (F1) The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). The reported transaction is an exempt transaction with the Issuer.
2 Common Common Stock 2025-12-11 M A 95,785 $0.00 175,196 D — —
3 Common Common Stock 2025-12-11 S D 100,000 $14.00 186,865 D — —
4 Common Common Stock 2025-12-11 M A 70,875 $0.00 405,758 D — —
5 Common Common Stock 2025-12-11 F D 118,893 $14.00 286,865 D — —
6 Common Common Stock 2025-12-11 M A 159,687 $0.00 334,883 D — —
7 Derivative Stock Option (Right to Buy) 2025-09-05 M D 40,000 $0.00 0 D $2.45 · — to 2025-11-10 40,000 Common Stock (F1) The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). The reported transaction is an exempt transaction with the Issuer. (F4) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on October 26, 2019.
8 Derivative Restricted Stock Units 2025-10-13 A A 284,200 $0.00 284,200 D — · — to — 284,200 Common Stock (F1) The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). The reported transaction is an exempt transaction with the Issuer. (F5) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F6) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering, as well as a service-based vesting schedule. The award shall vest as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on March 15, 2026. (F7) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
9 Derivative Restricted Stock Units 2025-12-11 M D 70,875 $0.00 307,125 D — · — to — 70,875 Common Stock (F5) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F10) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2025. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. (F7) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
10 Derivative Restricted Stock Units 2025-12-11 M D 159,687 $0.00 205,313 D — · — to — 159,687 Common Stock (F5) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F9) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2024. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. (F7) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
11 Derivative Restricted Stock Units 2025-12-11 M D 95,785 $0.00 0 D — · — to — 95,785 Common Stock (F5) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F8) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. The award was fully time-vested as of December 15, 2024, and the entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F7) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.